1995
DOI: 10.1038/bjc.1995.80
|View full text |Cite
|
Sign up to set email alerts
|

Plasminogen activators and inhibitor type 1 in neoplastic colonic tissue from patients with familial adenomatous polyposis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
10
0
1

Year Published

1997
1997
2014
2014

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 20 publications
(11 citation statements)
references
References 21 publications
0
10
0
1
Order By: Relevance
“…Increased levels of uPA in tumour tissue from patients have been associated with an overall poor prognosis 8–10. Additional studies in patients with familial adenomatous polyposis (FAP), an inherited form of colon cancer, indicated that uPA levels are higher during the transition from normal‐appearing colonic mucosa to neoplastic lesions, thus implicating uPA in the early stages of tumour development 11.…”
Section: Introductionmentioning
confidence: 99%
“…Increased levels of uPA in tumour tissue from patients have been associated with an overall poor prognosis 8–10. Additional studies in patients with familial adenomatous polyposis (FAP), an inherited form of colon cancer, indicated that uPA levels are higher during the transition from normal‐appearing colonic mucosa to neoplastic lesions, thus implicating uPA in the early stages of tumour development 11.…”
Section: Introductionmentioning
confidence: 99%
“…Sonoshita et al [96] studied murine and human tissue and showed that the transcriptional modulator enhancer of split (Aes) prevented CRC cells from intravasation through the impairment of trans-endothelial invasion that followed Notch-dependent mechanisms. Concurrently, urokinase plasminogen activator (uPA) expression is increased in patients with FAP during the transformation of normal to dysplastic epithelia [97,98] . The uPA system consists of uPA, the uPA receptor (uPAR), the tissue-type plasminogen activator (tPA), the plasminogen (Plg) and plasminogen activator inhibitors 1 and 2 (PAI-1 and PAI-2).…”
Section: Survival In the Lymphatic And/or The Blood Vesselsmentioning
confidence: 99%
“…5,19,21,38 The ability of cells to survive in the face of loss of cell contact is a marker of tumor progression, 13 and malignant transformation, invasion, and metastasis are linked to future somatic mutations, activation of oncogenes, inactivation of tumor suppresser genes, and upregulation of plasminogen activators and inhibitors. 33,35 Adenomas and carcinomas are derived from undifferentiated crypt stem cells, which retain their ability for multidirectional differentiation. Ninety-two percent of FAP carcinomas have Paneth cell differentiation, 99% have endocrine differentiation, and the number of well-differentiated mucus-secreting cells in dysplastic epithelium has been considered an indicator of the severity of the lesion.…”
mentioning
confidence: 99%